ADMA logo

ADMA Biologics (ADMA) Accounts Payable

Annual Accounts Payable

$15.66 M
+$2.43 M+18.38%

December 31, 2023


Summary


Performance

ADMA Accounts Payable Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

High & Low

Earnings dates

OtherADMAbalance sheetmetrics:

Quarterly Accounts Payable

$16.02 M
+$1.84 M+12.98%

September 30, 2024


Summary


Performance

ADMA Quarterly Accounts Payable Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

High & Low

Earnings dates

OtherADMAbalance sheetmetrics:

Accounts Payable Formula

Accounts Payable = Beginning Accounts Payable + Purchases on Credit − Payments to Suppliers

ADMA Accounts Payable Trends

PeriodPeriodAnnualAnnualQuarterlyQuarterly
1 y1 year+18.4%0.0%
3 y3 years+41.4%+21.1%
5 y5 years+165.4%+21.1%

ADMA Accounts Payable Highs & Lows

PeriodPeriodAnnual vs highAnnual vs highAnnual vs lowAnnual vs lowQuarter. vs highQuarter. vs highQuarter. vs lowQuarter. vs low
3 y3-yearat high+26.0%-36.4%+47.6%
5 y5-yearat high+70.7%-36.4%+159.8%
alltimeall timeat high+1379.2%-36.4%+3048.0%

ADMA Biologics Accounts Payable History

DateAnnualQuarterly
Sep 2024
-
$16.02 M(+13.0%)
Jun 2024
-
$14.18 M(-17.5%)
Mar 2024
-
$17.19 M(+9.7%)
Dec 2023
$15.66 M(+18.4%)
$15.66 M(+44.3%)
Sep 2023
-
$10.85 M(-10.2%)
Jun 2023
-
$12.08 M(-6.7%)
Mar 2023
-
$12.96 M(-2.1%)
Dec 2022
$13.23 M(+6.4%)
$13.23 M(-47.5%)
Sep 2022
-
$25.20 M(+121.3%)
Jun 2022
-
$11.39 M(-19.3%)
Mar 2022
-
$14.12 M(+13.6%)
Dec 2021
$12.43 M(+12.2%)
$12.43 M(-28.1%)
Sep 2021
-
$17.28 M(+180.2%)
Jun 2021
-
$6.17 M(-49.3%)
Mar 2021
-
$12.15 M(+9.7%)
Dec 2020
$11.07 M(+20.7%)
$11.07 M(+38.8%)
Sep 2020
-
$7.98 M(+15.5%)
Jun 2020
-
$6.91 M(-24.5%)
Mar 2020
-
$9.15 M(-0.2%)
Dec 2019
$9.17 M(+55.5%)
$9.17 M(+2.4%)
Sep 2019
-
$8.96 M(+32.0%)
Jun 2019
-
$6.79 M(+23.9%)
Mar 2019
-
$5.48 M(-7.1%)
Dec 2018
$5.90 M
$5.90 M(+12.0%)
Sep 2018
-
$5.27 M(+69.9%)
DateAnnualQuarterly
Jun 2018
-
$3.10 M(-45.8%)
Mar 2018
-
$5.72 M(-3.4%)
Dec 2017
$5.92 M(+130.9%)
$5.92 M(-35.3%)
Sep 2017
-
$9.16 M(+96.0%)
Jun 2017
-
$4.67 M(+19.7%)
Mar 2017
-
$3.90 M(+52.2%)
Dec 2016
$2.56 M(+22.8%)
$2.56 M(-7.7%)
Sep 2016
-
$2.78 M(-16.3%)
Jun 2016
-
$3.32 M(+34.4%)
Mar 2016
-
$2.47 M(+18.2%)
Dec 2015
$2.09 M(+17.4%)
$2.09 M(-4.4%)
Sep 2015
-
$2.18 M(+32.6%)
Jun 2015
-
$1.65 M(-7.4%)
Mar 2015
-
$1.78 M(-0.0%)
Dec 2014
$1.78 M(-34.3%)
$1.78 M(-27.2%)
Sep 2014
-
$2.44 M(+4.5%)
Jun 2014
-
$2.34 M(-15.3%)
Mar 2014
-
$2.76 M(+2.0%)
Dec 2013
$2.71 M(+155.9%)
$2.71 M(+82.8%)
Sep 2013
-
$1.48 M(+27.9%)
Jun 2013
-
$1.16 M(-16.0%)
Mar 2013
-
$1.38 M(+30.3%)
Dec 2012
$1.06 M
$1.06 M(+18.8%)
Sep 2012
-
$890.80 K(+12.6%)
Jun 2012
-
$790.90 K(+55.4%)
Mar 2012
-
$508.90 K

FAQ

  • What is ADMA Biologics annual accounts payable?
  • What is the all time high annual accounts payable for ADMA Biologics?
  • What is ADMA Biologics annual accounts payable year-on-year change?
  • What is ADMA Biologics quarterly accounts payable?
  • What is the all time high quarterly accounts payable for ADMA Biologics?
  • What is ADMA Biologics quarterly accounts payable year-on-year change?

What is ADMA Biologics annual accounts payable?

The current annual accounts payable of ADMA is $15.66 M

What is the all time high annual accounts payable for ADMA Biologics?

ADMA Biologics all-time high annual accounts payable is $15.66 M

What is ADMA Biologics annual accounts payable year-on-year change?

Over the past year, ADMA annual accounts payable has changed by +$2.43 M (+18.38%)

What is ADMA Biologics quarterly accounts payable?

The current quarterly accounts payable of ADMA is $16.02 M

What is the all time high quarterly accounts payable for ADMA Biologics?

ADMA Biologics all-time high quarterly accounts payable is $25.20 M

What is ADMA Biologics quarterly accounts payable year-on-year change?

Over the past year, ADMA quarterly accounts payable has changed by $0.00 (0.00%)